ProtoKinetix IncOTCQB:PKTX
- LAST PRICE0.0186
- TODAY'S CHANGE (%)0.0001 (0.5405%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0186 / 0.0185
- Day Range
- 52 Week Range
- Volume29,500
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | PKTX |
|---|---|---|
| 10:50 ET | 5000 | 0.01855 |
| 10:51 ET | 19500 | 0.0186 |
| 11:27 ET | 5000 | 0.0186 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
ProtoKinetix Inc | 6.4M | -15.0x | --- |
Enveric Biosciences Inc | 6.3M | -0.1x | --- |
Kazia Therapeutics Ltd | 9.9M | -0.5x | --- |
Creative Medical Technology Holdings Inc | 6.6M | -1.3x | --- |
eFFECTOR Therapeutics Inc | 6.6M | -0.1x | --- |
TC BioPharm Ltd | 5.0M | 0.0x | --- |
Company Information
ProtoKinetix, Incorporated is a research and development stage biotechnology company. The Company is focused on scientific medical research of Anti-Freeze Glycoproteins (AFGPs) or anti-aging glycoproteins. The Company’s anti-aging glycopeptide is for ophthalmology, dermatology, transplant support and biomanufacturing. The commercial applications for AAGPs include various health care solutions. In a clinical setting, AAGP is showing its ability to protect cells from inflammation, repair and replace damaged cells and improve cell survivability over time. The Company has not developed a commercially viable product and has not generated any revenue.
Contact Information
- Headquarters
- 109 W. MAIN ST.DALTON, OH, United States 44618
- Phone
- 330-445-4971
- Fax
- 604-926-6632
Executives
- Chairman of the Board, President, Chief Executive Officer
- Clarence Smith
- Chief Financial Officer
- Michael Guzzetta
- Independent Director
- Edward McDonough
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $6.4M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 346.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -0.10 |
EPS | $0.00 |
Book Value | $0.00 |
P/E Ratio | -15.0x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
